Stay updated on Immunologic Response to Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Immunologic Response to Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunologic Response to Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The site revision identifier changes from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-01T15:42:50.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and points visitors to related updates and FAQs.
    Difference
    0.6%
    Check dated 2026-10-25T14:56:50.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T15:13:22.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site footer revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T14:57:55.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The record history shows a new revision entry (v3.7.0) replacing the previous revision (v3.6.6), indicating an updated version of the record.
    Difference
    0.1%
    Check dated 2026-09-20T19:58:42.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    A new revision entry v3.6.6 was added to the study record history. The previous revision v3.6.5 was removed from the latest history view.
    Difference
    0.1%
    Check dated 2026-08-30T21:50:51.000Z thumbnail image

Stay in the know with updates to Immunologic Response to Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunologic Response to Pembrolizumab in Melanoma Clinical Trial page.